Q5151 Inj, eculizumab-aagh, 2 mg

Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 600 units per day (practitioner), rationale: Prescribing Information